Incstar Corp. (ASE:ISR) announced that it has acquired anadvanced fluorescence polarization immunoassay (FPIA)medical diagnostic technology from Dallas research firm RobertDowben Associates.

Incstar's systems will now use a new fluorescent dye and fullyautomated instrumentation for the immunoassays.

Stillwater, Minn.-based Incstar, an affiliate of the Italian-basedFiat Group (NYSE:FIA), manufactures and distributesimmunodiagnostic products for health care professionals andmanufacturers.

(c) 1997 American Health Consultants. All rights reserved.

No Comments